Open Access. Powered by Scholars. Published by Universities.®
Skin and Connective Tissue Diseases Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Dermatology (32)
- Oncology (9)
- Life Sciences (7)
- Biochemistry, Biophysics, and Structural Biology (5)
- Biological Phenomena, Cell Phenomena, and Immunity (4)
-
- Mental and Social Health (4)
- Biology (3)
- Infectious Disease (3)
- Internal Medicine (3)
- Medical Immunology (3)
- Pediatrics (3)
- Social and Behavioral Sciences (3)
- Surgery (3)
- Hemic and Lymphatic Diseases (2)
- Medical Cell Biology (2)
- Obstetrics and Gynecology (2)
- Public Health (2)
- Race and Ethnicity (2)
- Sociology (2)
- Communication (1)
- Dentistry (1)
- Digestive System Diseases (1)
- Epidemiology (1)
- Gastroenterology (1)
- Genetic Phenomena (1)
- Keyword
-
- Humans (6)
- Female (3)
- Middle Aged (3)
- Squamous cell carcinoma (3)
- Acne (2)
-
- Adult (2)
- Bartonella henselae (2)
- Case report (2)
- Cyst (2)
- Dermatology (2)
- Isotretinoin (2)
- Male (2)
- Melanoma (2)
- Mohs surgery (2)
- Retrospective Studies (2)
- Skin of color (2)
- United States (2)
- 80 and over (1)
- ACL reconstruction (1)
- Abortion (1)
- Abstinence (1)
- Accutane (1)
- Acquired immunodeficiency syndrome (1)
- Adolescents (1)
- Adverse drug reactions (1)
- African tick bite fever (1)
- Aged (1)
- Aged, 80 and over (1)
- Aids (1)
- Allograft (1)
Articles 31 - 35 of 35
Full-Text Articles in Skin and Connective Tissue Diseases
Safety And Efficacy Profile Of Ozenoxacin 1% Cream In Pediatric Patients With Impetigo, Adelaide A Hebert, Theodore Rosen, Núria Albareda López, Ilonka Zsolt, Xavier Masramon
Safety And Efficacy Profile Of Ozenoxacin 1% Cream In Pediatric Patients With Impetigo, Adelaide A Hebert, Theodore Rosen, Núria Albareda López, Ilonka Zsolt, Xavier Masramon
Faculty, Staff and Students Publications
BACKGROUND: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups.
METHODS: Data for children aged 2 months to <18 years recruited from eight countries who had participated in phase 1 and 3 trials of ozenoxacin were extracted and analyzed by age range.
RESULTS: Across studies, 644 pediatric patients with impetigo received ozenoxacin 1% cream (n = 287) or vehicle (n = 247). One study included retapamulin 1% ointment as the internal validity control (n = 110). The clinical success rate at the end of treatment and bacterial eradication rates after 3 to 4 days of treatment and at …
18>Probable African Tick Bite Fever In The United States, Kami Lowery, Theodore Rosen
Probable African Tick Bite Fever In The United States, Kami Lowery, Theodore Rosen
Faculty, Staff and Students Publications
African tick bite fever (ATBF) is a tick-borne rickettsial disease most often observed in North American and European tourists returning home from the southern portion of Africa. Ticks infected with Rickettsia africae transmit this parasitic bacterium to humans, who subsequently develop an influenza-like illness, one or more inoculation eschars, and in some cases, a cutaneous rash. Because ATBF often presents with non-specific symptoms that suggest other infectious diseases, establishing the diagnosis may be difficult. Confirmatory assays, including serology and nucleic acid amplification, may take weeks to return and cannot help with acute treatment decisions. We present a case of a …
Risk Factors For Early Subsequent (Revision Or Contralateral) Acl Reconstruction: A Retrospective Database Study, Matthew C Gallo, Ioanna K Bolia, Omid Jalali, Santano Rosario, Alexis Rounds, Keemia Soraya Heidari, Nicholas A Trasolini, John P Prodromo, George Frederick Hatch, Alexander Evan Weber
Risk Factors For Early Subsequent (Revision Or Contralateral) Acl Reconstruction: A Retrospective Database Study, Matthew C Gallo, Ioanna K Bolia, Omid Jalali, Santano Rosario, Alexis Rounds, Keemia Soraya Heidari, Nicholas A Trasolini, John P Prodromo, George Frederick Hatch, Alexander Evan Weber
Faculty, Staff and Students Publications
BACKGROUND: Many factors contribute to the risk for subsequent anterior cruciate ligament reconstruction (ACLR) within 2 years from the index procedure.
PURPOSE/HYPOTHESIS: The purpose of this study was 2-fold: (1) to evaluate the incidence of subsequent (revision or contralateral) ACLR at 2 years in a large cohort and (2) to explore the association between patient-specific factors and early subsequent ACLR risk by age group. We hypothesize that 2-year subsequent (revision or contralateral) ACLR rates will be low and that risk factors for subsequent (revision or contralateral) ACLR will vary depending on a patient's age group.
STUDY DESIGN: Case-control study; Level …
A Retrospective Matched-Cohort Study Of 3994 Lower Extremity Wounds Of Multiple Etiologies Across 644 Institutions Comparing A Bioactive Human Skin Allograft, Theraskin, Plus Standard Of Care, To Standard Of Care Alone, Geoff C Gurtner, Aimee D Garcia, Katie Bakewell, Jason B Alarcon
A Retrospective Matched-Cohort Study Of 3994 Lower Extremity Wounds Of Multiple Etiologies Across 644 Institutions Comparing A Bioactive Human Skin Allograft, Theraskin, Plus Standard Of Care, To Standard Of Care Alone, Geoff C Gurtner, Aimee D Garcia, Katie Bakewell, Jason B Alarcon
Faculty, Staff and Students Publications
Most chronic wounds are related to comorbidities, for which no clinical trials are performed. This retrospective propensity matched-cohort study examined data from 2 074 000 lower extremity wounds across 644 institutions to determine the effectiveness of TheraSkin plus standard of care (SOC; n = 1997) versus SOC alone (n = 1997). Multivariate modelling comparing outcomes such as healing rates, percent area reductions (PARs), amputations, recidivism, treatment completion, and medical transfers were evaluated. A higher proportion of wounds in the treatment group compared with the controls were more likely to close (68.3% versus 60.3%), particularly wounds with exposed structures (64% versus …
Reduced Bacterial Burden Of The Skin Surrounding The Shoulder Joint Following Topical Protocatechuic Acid Application: Results Of A Pilot Study, Omid Jalali, Molly Best, Alison Wong, Brett Schaeffer, Brendon Bauer, Lanny Johnson
Reduced Bacterial Burden Of The Skin Surrounding The Shoulder Joint Following Topical Protocatechuic Acid Application: Results Of A Pilot Study, Omid Jalali, Molly Best, Alison Wong, Brett Schaeffer, Brendon Bauer, Lanny Johnson
Faculty, Staff and Students Publications
BACKGROUND: Reducing the rising health-care burden associated with shoulder surgical site infection (SSI) is of paramount importance. The purpose of this study was to investigate the antimicrobial efficacy of protocatechuic acid (PCA) as a topical reagent for surgical skin antisepsis surrounding the shoulder joint.
METHODS: This was a 2-phase skin-disinfection trial involving the human shoulder. The shoulders of healthy volunteers were randomized to topical treatment with PCA (a 10% concentration of PCA in Phase I [11 subjects] and a 17% concentration in Phase II [12 subjects]), with a control of isopropyl alcohol (IPA) applied to the contralateral shoulder. Mechanical scraping …